Ondrej Slaby

9PUBLICATIONS
28CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersCancer geneticsPharmacogenomics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Aug 04, 2025
Real-World Data From a Molecular Tumor Board-Assisted Cancer Care From a Single Center in The Czech Republic: Is Precision Oncology an Accessible Option, or a Privilege for a Minority of Patients?

Michal Eid, Markéta Bednaříková, Jakub Vlažný

|Apr 21, 2025
Neoadjuvant treatment of locally advanced rectal cancer - a consensus procedure Comprehensive Cancer Center Brno.

P Pospíšil, E Dvořáková, P Šlampa

|Feb 10, 2025
Minimal invasive surgery of pancreatic cancer at the Department of Surgery of Masaryk university hospital Brno, Czech Republic.

J Hlavsa, T Pavlík, D Marek

|Dec 07, 2024
The role of neoadjuvant treatment in localized pancreatic cancer.

R Němeček, M Eid

|May 22, 2024
Incidental germline findings during comprehensive genomic profiling of pancreatic and colorectal cancer: single-centre, molecular tumour board experience.

Michal Eid, Jakub Trizuljak, Renata Taslerova

|May 05, 2023
Management of pheochromocytomas and paragangliomas: Review of current diagnosis and treatment options.

Michal Eid, Jakub Foukal, Dana Sochorová

Pageof 2

Frequent Collaborators

3 joint publications

Zdeněk Kala

3 joint publications

Jan Trna

3 joint publications

Lumír Kunovský

2 joint publications

Radim Němeček